Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acrivon Therapeutics, Inc. - Common Stock
(NQ:
ACRV
)
9.360
+0.670 (+7.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acrivon Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
Acrivon Therapeutics to Present at the Stifel 2023 Targeted Oncology Days Conference
April 18, 2023
From
Acrivon Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
April 07, 2023
Via
Benzinga
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 28, 2023
From
Acrivon Therapeutics, Inc
Via
GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 20, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 20, 2023
Via
Benzinga
Acrivon Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 06, 2023
From
Acrivon Therapeutics, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
February 27, 2023
Via
Benzinga
Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday
February 27, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Acrivon Therapeutics to Participate on a Panel at Cowen’s 43rd Annual Health Care Conference
February 27, 2023
CEO to participate on ovarian cancer panel and will highlight ACR-368, a DNA Damage Response (DDR) inhibitor in clinical testing for platinum-resistant advanced ovarian cancer and other solid tumors
From
Acrivon Therapeutics, Inc
Via
GlobeNewswire
2 Breakout Growth Stocks to Buy for the Long Haul
February 14, 2023
These two healthcare stocks have crushed the broader markets this year.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
November 22, 2022
Although US stocks closed mostly lower on Monday, there were a few notable insider trades.
Via
Benzinga
Carvana, Crocs And Other Big Losers From Monday
November 22, 2022
U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
November 22, 2022
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.